“…Nanotechnology is increasingly being developed as one of the novel strategies in the field of biomedicine. − Nanomaterials have unique advantages in antibacterial applications over other materials owing to their ultra-small size, large surface area-to-mass ratio, high reactivity, and enriched multifunction integration. − Particularly, magnetic nanoparticles (MNPs), approved by the U.S. Food and Drug Administration (FDA), have achieved great prominence in the antimicrobial therapy owing to their small size and high magnetism, immunoregulatory activity, feasible large-scale production, cell membrane penetrability, biocompatibility, and flexible surface functionalization. − For instance, MNPs have been used to combat the bacterial infections, such as Escherichia coli, Staphylococcus aureus [specifically Methicillin-resistant Staphylococcus Aureus (MRSA)], Salmonella enteritidis, and so forth, which have been applied to wound, blood, skin, and orthopedic and liver diseases. − However, MNPs were not effective in removing biofilms. , …”